Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avicanna Inc T.AVCN

Alternate Symbol(s):  AVCNF

Avicanna Inc. is a Canada-based commercial-stage international biopharmaceutical company. The Company's scientific platform commercializes over thirty products across various market segments: Medical Cannabis formulary (RHO Phyto), Medical cannabis care platform (MyMedi.ca), Pharmaceutical pipeline, and Active pharmaceutical ingredients (Aureus Santa Marta). RHO Phyto formulary offers a diverse range of proprietary products, including oral, sublingual, topical, and transdermal deliveries with varying ratios of cannabinoids. MyMedi.ca is a medical cannabis care platform and features a diverse portfolio of products and bilingual pharmacist-led patient support programs. Aureus Santa Mart is a commercial-stage business providing a various forms CBD, THC and CBG to the Company's international partners for use in the development and production of food, cosmetics, medical, and pharmaceutical products.


TSX:AVCN - Post by User

Bullboard Posts
Comment by Russell1on Jul 01, 2020 8:46am
83 Views
Post# 31211678

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Attention

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Attention

You delivered? To whom? Not your shareholders that bought in privately at $2 years ago, not to shareholders who bought in privately at $8 and certainly not to me when I purchased on the market above $7. That was the company line as shareholders watched the stock plummet..."we are the best, it's everyone else's fault this is happening". This is precisely the attitude that concerns me as a shareholder. Where is the responsibility for mistakes that led to this share price collapse? There always seems to be an excuse. You continue to say that the company is doing amazing things and it is "the most undervalued cannabis stock", you are disconnected from the reality of your situation mate. So if Avicanna is a stellar company and the news releases have been great (as one of your promotion team pointed out, although they were confused why nobody seemed to care which means they are terrible at their job if that wasn't already evident) then where does that leave things? I would propose that it is the inexperience of the executive team and their lack of leadership in the public markets that created this disconnect. That would be the only explanation for the share price collapse as the executive team shouted their own praises to the hills. Unfortunately companies aren't built on Hopeful123 nor on executives who spend their time attacking Stockhouse posts asking pertinent questions about the health of the company instead of trying to focus on building shareholder value. I am glad you are excited that the stock price will hit $2.50 or $3 in your best case projection, please don't forget about all of us shareholders who purchased shares well above these "dream" numbers.  

-Russ

Bullboard Posts